Cel Sci CVM
NYSE CVM
$1.42 -0.04 (-2.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cel Sci (CVM) Consolidated Net Income (2010 - 2026)

Cel Sci (CVM) posted Consolidated Net Income of -$13.0 million for Q1 2026, down 134.11% sequentially from -$5.5 million in Q4 2025, and down 97.11% YoY from -$447.6 million in Q1 2025.

Cel Sci (CVM) Consolidated Net Income (2010 - 2026) Analysis & Trends

Cel Sci has reported Consolidated Net Income for 17 years, with the latest figure at -$13.0 million in Q1 2026.

  • Quarterly Consolidated Net Income fell 97.11% year-over-year to -$13.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$41.6 million (down 6.86% YoY) and the FY2025 annual result came in at -$90.7 million, down 2.09% from the prior year.
  • Consolidated Net Income retreated to -$13.0 million in Q1 2026 per CVM's latest filing, from -$5.5 million in the prior quarter.
  • Over five years, Consolidated Net Income peaked at -$5.5 million in Q4 2025 and troughed at -$27.8 million in Q1 2022.
  • A 5-year average of -$14.6 million and a median of -$13.0 million in 2026 frame the typical range for Consolidated Net Income.
  • The sharpest annual moves came in 2023 and 2025: Consolidated Net Income plunged 154.62% in 2023, then surged 67.46% in 2025.
  • Over 5 years, Consolidated Net Income stood at -$8.0 million in 2022, then plunged by 154.62% to -$20.2 million in 2023, then soared by 64.92% to -$7.1 million in 2024, then climbed by 22.08% to -$5.5 million in 2025, then sank by 134.11% to -$13.0 million in 2026.
  • According to Business Quant data, Consolidated Net Income over the past three periods registered -$13.0 million, -$5.5 million, and -$7.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 482.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -174.37 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -13.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Cel Sci 2.12 Mn -4.42 Mn - -5.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -12.95 Mn
Dec 31, 2025 -5.53 Mn
Sep 30, 2025 -7.92 Mn
Jun 30, 2025 -15.22 Mn
Mar 31, 2025 -6.57 Mn
Dec 31, 2024 -7.10 Mn
Sep 30, 2024 -6.16 Mn
Jun 30, 2024 -19.13 Mn
Mar 31, 2024 -20.20 Mn
Dec 31, 2023 -20.24 Mn
Sep 30, 2023 -8.08 Mn
Jun 30, 2023 -23.25 Mn
Mar 31, 2023 -23.89 Mn
Dec 31, 2022 -7.95 Mn
Sep 30, 2022 -10.48 Mn
Jun 30, 2022 -26.34 Mn
Mar 31, 2022 -27.76 Mn
Dec 31, 2021 -9.13 Mn
Sep 30, 2021 -8.60 Mn
Jun 30, 2021 -10.48 Mn